Advanced search
Publication Cover
Hematology Volume 29, 2024 - Issue 1
Submit an article Journal homepage
890
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The prognostic significance of POD24 in peripheral T-cell lymphoma

Huimin Chena Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Ruixue Maa Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Qianqian Zhanga Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Fengyi Lua Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Yuhan Mab Department of Hematology, The First People's Hospital of Suqian, Suqian, People’s Republic of ChinaView further author information
,
Jingxin Zhoub Department of Hematology, The First People's Hospital of Suqian, Suqian, People’s Republic of ChinaView further author information
,
Jiang Caoa Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Kunming Qia Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Zhiling Yana Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Wei Sanga Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Feng Zhua Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Haiying Suna Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Depeng Lia Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Zhenyu Lia Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaView further author information
,
Hai Chenga Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Kailin Xua Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Wei Chena Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China;b Department of Hematology, The First People's Hospital of Suqian, Suqian, People’s Republic of China;c Blood Diseases Institute, Xuzhou Medical University, Xuzhou, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5480-6577View further author information
ORCID Icon show all
Article: 2304483 | Received 06 Aug 2023, Accepted 02 Jan 2024, Published online: 22 Jan 2024

References

  • Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124–4130. doi:10.1200/JCO.2008.16.4558
  • Casulo C, Byrtek M, Dawson KL, et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: An analysis from the national LymphoCare study. J Clin Oncol. 2015;33(23):2516–2522. doi:10.1200/JCO.2014.59.7534
  • Luminari S, Merli M, Rattotti S, et al. Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study. Blood. 2019;134(10):798–801. doi:10.1182/blood.2019001088
  • Yamaguchi M, Suzuki R, Kim SJ, et al. Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy. Cancer Sci. 2018;109(6):2056–2062. doi:10.1111/cas.13597
  • Advani RH, Skrypets T, Civallero M, et al. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project. Blood. 2021;138(3):213–220. doi:10.1182/blood.2020010387
  • Eskelund CW, Dimopoulos K, Kolstad A, et al. Detailed long-term follow-up of patients who relapsed after the Nordic mantle cell lymphoma trials: MCL2 and MCL3. Hemasphere. 2021;5(1):e510. doi:10.1097/HS9.0000000000000510
  • Suzuki Y, Yano T, Suehiro Y, et al. Evaluation of prognosis following early disease progression in peripheral T-cell lymphoma. Int J Hematol. 2020;112(6):817–824. doi:10.1007/s12185-020-02987-7
  • Du J, Yu D, Han X, et al. Comparison of allogeneic stem cell transplant and autologous stem cell transplant in refractory or relapsed peripheral T-cell lymphoma. JAMA Netw Open. 2021;4(5):e219807. doi:10.1001/jamanetworkopen.2021.9807
  • Wu M, Wang X, Xie Y, et al. Outcome and prospective factor analysis of high-dose therapy combined with autologous peripheral blood stem cell transplantation in patients with peripheral T-cell lymphomas. Int J Med Sci. 2018;15(9):867–874. doi:10.7150/ijms.23067
  • Liang X, Guo L, Hu X, et al. Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma. Medicine (Baltimore). 2021;100(13):e25194. doi:10.1097/MD.0000000000025194
  • Rodríguez M, Alonso-Alonso R, Tomás-Roca L, et al. Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers. Blood Adv. 2021;5(24):5588–5598. doi:10.1182/bloodadvances.2021005171
  • Gao H, Ji X, Liu X, et al. Conditional survival and hazards of death for peripheral T-cell lymphomas. Aging (Albany NY). 2021;13(7):10225–10239.
  • Kuzich JA, Hutchison AP, Lim KJC, et al. Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’ experience from Western Australia. Leuk Lymphoma. 2019;60(14):3417–3425. doi:10.1080/10428194.2019.1637865
  • Lyu R, Yan YT, Yi SH, et al. The prognostic significance of POD24 in 106 cases with splenic marginal lymphoma with bone marrow invasion. Zhonghua Xue Ye Xue Za Zhi. 2020;41(3):228–233.
  • Ruiz IC, Martelli M, Sehn LH, et al. Baseline total metabolic tumor volume is prognostic for refractoriness to immunochemotherapy in DLBCL: results from GOYA. Clin Lymphoma Myeloma Leuk. 2022;22(8):e804–e814. doi:10.1016/j.clml.2022.04.010
  • Yang Z, Zheng Y, Wu Z, et al. Association between pre-diagnostic serum albumin and cancer risk: results from a prospective population-based study. Cancer Med. 2021;10(12):4054–4065. doi:10.1002/cam4.3937
  • Yoon HS, Shu XO, Shidal C, et al. Associations of pre-diagnostic serum levels of total bilirubin and albumin with lung cancer risk: results from the southern community cohort study. Front Oncol. 2022;12:895479. doi:10.3389/fonc.2022.895479
  • Kühn T, Sookthai D, Graf ME, et al. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study. Br J Cancer. 2017;117(10):1572–1579. doi:10.1038/bjc.2017.313
  • Luo C, Li Q, Li X, et al. Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation. Ann Transplant. 2021;26:e933365.
  • Bairey O, Shacham-Abulafia A, Shpilberg O, et al. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor. Hematol Oncol. 2016;34(4):184–192. doi:10.1002/hon.2233
  • Ellin F, Landström J, Jerkeman M, et al. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish lymphoma registry. Blood. 2014;124(10):1570–1577.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.